-+ 0.00%
-+ 0.00%
-+ 0.00%

Evaxion to present new preclinical data on CMV vaccine candidate EVX-V1 at International Herpesvirus Workshop

PUBT·07/01/2026 12:06:14
Listen to the news
Evaxion to present new preclinical data on CMV vaccine candidate EVX-V1 at International Herpesvirus Workshop
  • Evaxion flagged new preclinical data for its EVX-V1 cytomegalovirus vaccine candidate, aimed at finalizing antigen selection for a broadly protective program.
  • The data will be presented in a poster session at the International Herpesvirus Workshop in Montreal on July 12, 2026.
  • EVX-V1 combines AI-discovered antigens with AI-optimized versions of established CMV vaccine antigens.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evaxion A/S published the original content used to generate this news brief on July 01, 2026, and is solely responsible for the information contained therein.